RAS pathway activation and an oncogenic RAS mutation in sporadic pilocytic astrocytoma

Neurology

Volumn 65, Issue 8, 2005, Pages 1335-1336

  Sharma, Mukesh K ^a   Zehnbauer, Barbara A ^a   Watson, Mark A ^a   Gutmann, David H ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROFIBROMIN;

ARTICLE; ASTROCYTOMA; GENE; GENE ACTIVATION; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALIGNANT TRANSFORMATION; NF1 GENE; ONCOGENE K RAS; PRIORITY JOURNAL;

EID: 27144540888     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000180409.78098.d7     Document Type: Article

References (7)

1. Gutmann DH, Donahoe J, Brown T, James CD, Perry A. Loss of neurofibromatosis 1 (NF1) gene expression in NF1-associated pilocytic astrocytomas. Neuropathol Appl Neurobiol 2000;26:361-367.
2. Wimmer K, Eckart M, Meyer-Puttlitz B, Fonatsch C, Pietsch T. Mutational and expression analysis of the NF1 gene argues against a role as a tumor suppressor in sporadic pilocytic astrocytomas. J Neuropathol Exp Neurol 2002;61:896-902.
3. Tartaglia M, Niemeyer CM, Fragale A, et al. Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia. Nat Genet 2003;34:148-150.
4. Loh ML, Vattikuti S, Schubbert S, et al. Mutations in PTPN11 implicate the SHP-2 phosphatase in leukemogenesis. Blood 2004;103:2325-2331.
5. Gressani KM, Rollins LA, Leone-Kabler S, Cline JM, Miller MS. Induction of mutations in Ki-ras and INK4a in liver tumors of mice exposed in utero to 3-methylcholanthrene. Carcinogenesis 1998;19:1045-1052.
6. Dasgupta B, Li W, Perry A, Gutmann DH. Glioma formation in neurofibromatosis 1 reflects preferential activation of K-RAS in astrocytes. Cancer Res 2005;65:236-245.
7. Li J, Perry A, James CD, Gutmann DH. Cancer-related gene expression profiles in NF1-associated pilocytic astrocytomas. Neurology 2001;56:885-890.